These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 30144998

  • 61. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk.
    Iio K, Morikawa Y, Miyata K, Kaneko T, Misawa M, Yamagishi H, Miura M.
    Pediatr Infect Dis J; 2023 Jul 01; 42(7):608-613. PubMed ID: 37053581
    [Abstract] [Full Text] [Related]

  • 62. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores.
    Son MBF, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR, Lo MS, Baker AL, Sundel RP, Newburger JW.
    J Am Heart Assoc; 2017 May 31; 6(6):. PubMed ID: 28566299
    [Abstract] [Full Text] [Related]

  • 63. Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease.
    Nakashima Y, Nanishi E, Yamamura K, Uike K, Terashi E, Hirata Y, Nagata H, Morihana E, Tanaka T, Honjo S, Takada H, Ohga S.
    Cytokine; 2019 Feb 31; 114():26-31. PubMed ID: 30583086
    [Abstract] [Full Text] [Related]

  • 64. The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis.
    Li D, Li X, Dou W, Zheng Y.
    Transl Pediatr; 2021 May 31; 10(5):1294-1306. PubMed ID: 34189087
    [Abstract] [Full Text] [Related]

  • 65. Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review.
    Chen J, Liao J, Xiang L, Zhang S, Yan Y.
    Front Immunol; 2023 May 31; 14():1237670. PubMed ID: 37936712
    [Abstract] [Full Text] [Related]

  • 66. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
    Michihata N, Matsui H, Fushimi K, Yasunaga H.
    Clin Pediatr (Phila); 2015 Oct 31; 54(11):1076-80. PubMed ID: 25573948
    [Abstract] [Full Text] [Related]

  • 67. The relationship between TNF-like protein 1A and coronary artery aneurysms in children with Kawasaki disease.
    Zhang J, Weng H, Pei Q, Yang P, Fan W, Liu R, Yi Q.
    Clin Exp Med; 2022 Feb 31; 22(1):57-63. PubMed ID: 34232416
    [Abstract] [Full Text] [Related]

  • 68. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
    Pediatr Cardiol; 2003 Feb 31; 24(2):122-6. PubMed ID: 12457252
    [Abstract] [Full Text] [Related]

  • 69. Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm.
    Oishi T, Fujieda M, Shiraishi T, Ono M, Inoue K, Takahashi A, Ogura H, Wakiguchi H.
    Circ J; 2008 May 31; 72(5):850-2. PubMed ID: 18441471
    [Abstract] [Full Text] [Related]

  • 70. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.
    Burns JC, Song Y, Bujold M, Shimizu C, Kanegaye JT, Tremoulet AH, Franco A.
    Clin Exp Immunol; 2013 Dec 31; 174(3):337-44. PubMed ID: 23901839
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Evaluation of the Association Between Coronary Artery Aneurysms and Concomitant Infection in Patients With Kawasaki Disease.
    Liu J, Su D, Qin S, Ye B, Wang B, Pang Y.
    Clin Pediatr (Phila); 2024 Jun 31; 63(6):785-797. PubMed ID: 37642409
    [Abstract] [Full Text] [Related]

  • 74. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA.
    Arch Dis Child; 2015 Apr 31; 100(4):366-8. PubMed ID: 25670405
    [Abstract] [Full Text] [Related]

  • 75. Heart Rate, Responsiveness to Intravenous Immunoglobulin, and Coronary Artery Aneurysms in Kawasaki Disease.
    Miyakoshi C, Yamamoto Y, Yamakawa M, Fukuhara S.
    J Pediatr; 2018 Sep 31; 200():160-165.e5. PubMed ID: 29793867
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Development of a nomogram prediction model for early identification of persistent coronary artery aneurysms in kawasaki disease.
    Gong X, Tang L, Wu M, Shao S, Zhou K, Hua Y, Wang C, Li Y.
    BMC Pediatr; 2023 Feb 16; 23(1):79. PubMed ID: 36797697
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor.
    Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Feb 16; 168(2):157-62. PubMed ID: 18478263
    [Abstract] [Full Text] [Related]

  • 80. Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review.
    Crayne CB, Mitchell C, Beukelman T.
    Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):77. PubMed ID: 31775898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.